Indeed, loss of SFRP1 increases Wnt signaling in mammary epithelial cells [3], a deleterious effect considering that inappropriate activation of the Wnt/β-catenin pathway contributes to the development of breast cancer [7]. Here, SFRP1 is linked to breast carcinoma.